Good Therapeutics

Based in the United States, Good Therapeutics is a startup. Good Therapeutics has been acquired. Brouky classifies it under Healthcare & Life Sciences.

Good Therapeutics develops regulated protein therapeutics using antibody-controlled mechanisms that activate only when bound to their targets, focusing primarily on cytokine-based treatments for cancer and potential applications in autoimmune diseases, metabolic disorders, and pain management.